GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (FRA:N04) » Definitions » Valuation Rank

NuCana (FRA:N04) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is NuCana Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

NuCana Valuation Rank Related Terms

Thank you for viewing the detailed overview of NuCana's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

NuCana Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (FRA:N04) » Definitions » Valuation Rank
Comparable Companies
ENZN NKGN AIM BTAI APLM INDP ALZN PSTV BCLI LIPO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
NCNA:USA
Address
3 Lochside Way, Edinburgh, GBR, EH12 9DT
Website
https://www.nucana.com
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.